MX2023013066A - Formulaciones de etelcalcetida. - Google Patents

Formulaciones de etelcalcetida.

Info

Publication number
MX2023013066A
MX2023013066A MX2023013066A MX2023013066A MX2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A MX 2023013066 A MX2023013066 A MX 2023013066A
Authority
MX
Mexico
Prior art keywords
etelcalcetide
formulations
surfactant
formulation
salt
Prior art date
Application number
MX2023013066A
Other languages
English (en)
Spanish (es)
Inventor
David Lai
Kakhki Iman Mirzaee
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of MX2023013066A publication Critical patent/MX2023013066A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MX2023013066A 2021-05-06 2022-05-03 Formulaciones de etelcalcetida. MX2023013066A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163184924P 2021-05-06 2021-05-06
PCT/US2022/027451 WO2022235654A1 (en) 2021-05-06 2022-05-03 Etelcalcetide formulations

Publications (1)

Publication Number Publication Date
MX2023013066A true MX2023013066A (es) 2023-11-15

Family

ID=81750502

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023013066A MX2023013066A (es) 2021-05-06 2022-05-03 Formulaciones de etelcalcetida.

Country Status (7)

Country Link
US (1) US20240207354A1 (https=)
EP (1) EP4333805A1 (https=)
JP (1) JP2024517801A (https=)
AU (1) AU2022268916A1 (https=)
CA (1) CA3218559A1 (https=)
MX (1) MX2023013066A (https=)
WO (1) WO2022235654A1 (https=)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
MX2012000100A (es) * 2009-07-01 2012-04-02 Fresenius Med Care Hldg Inc Dispositivos de suministro de farmaco y sistemas y metodos relacionados.
MA38724B1 (fr) 2013-06-28 2017-11-30 Amgen Inc Formulation liquide stable d'amg 416 (velcalcétide)
WO2021080822A1 (en) * 2019-10-24 2021-04-29 Amgen Inc. Systems and methods for drug delivery

Also Published As

Publication number Publication date
WO2022235654A1 (en) 2022-11-10
US20240207354A1 (en) 2024-06-27
CA3218559A1 (en) 2022-11-10
AU2022268916A1 (en) 2023-11-09
EP4333805A1 (en) 2024-03-13
JP2024517801A (ja) 2024-04-23

Similar Documents

Publication Publication Date Title
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
MX2009000147A (es) Formulaciones de locion en aerosol.
UY26269A1 (es) Formulación de sal común y moxifloxacina
IN2015MU00865A (https=)
MX2017007178A (es) Formulaciones liquidas estables de virus de vacuna.
AR074541A1 (es) Composiciones desinfectantes de plata naturales
HUP0401811A2 (hu) Javított vízoldékonyságú gyógyszerkészítmény és eljárás az előállítására
MX392529B (es) Formulacion de neurotoxina.
NZ738597A (en) Stuffy nose deblocking composition having antiviral activity
MX2011010781A (es) Una crema medicinal hecha con sulfadiazina de plata y quitosano y un proceso para hacerla.
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
EP3957655A4 (en) ETHYLENE VINYL ALCOHOL COPOLYMER AND AQUEOUS SOLUTION WITH USE THEREOF
AR111550A1 (es) Formulaciones de ácido 1-amino-1-ciclopropanocarboxílico
TN2014000152A1 (en) Sustained-release preparation
PH12022550264A1 (en) Fungicide composition
MX2023013066A (es) Formulaciones de etelcalcetida.
CR8473A (es) Composicion farmaceutica de vinflunina para administracion parenteral y proceso de preparacion de dicha composicion
TN2023000279A1 (en) Oral solution based on citicoline and nicotinamide for use in the treatment of glaucoma
AR046634A1 (es) Una suspension fungicida acuosa concentrada
PH12021550236A1 (en) Thickener combination for agrochemical (crop protection) formulations with high salt content
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
PL431139A1 (pl) Kompozycja farmaceutyczna bimatoprostu i tymololu
CA2903759C (en) Concentrated aqueous azalide formulations
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv